To address the limitations of bulk RNA profiling in discerning cellular subsets and the relative contributions of cells to IFNγ signaling, we performed scRNA profiling on 20 bone marrow aspirates from AML patients at the time of their diagnosis. This evidence concerns the gene IFNG and acute myeloid leukemia.